Risk Partners Life Sciences Roundtable 2024, thank you very much! Already for the 26.06.2025 >

Growth capital for biotechnology
and life sciences - Finance Day 2024

A few days ago, Jutta and Florian from our team attended Finance Day 2024 at the analytica trade fair in Munich. The event once again offered exciting expert panels on current financing and capital market issues for life sciences companies. As the panels focused on three of our key consulting areas, namely life sciences, venture capital and IPOs, attending was of course a must for us as a specialist insurance broker. Our team was also delighted to meet many of our partners and clients again and talk to them about the importance of risk management and insurance solutions.

The startup panel was also interesting and once again demonstrated the innovative spirit of the industry. Ten companies were selected for this, nine of which were even presented in person by a founder. Take a look at the companies and if you are interested in the product or an investment, please contact the ladies or gentlemen directly. We are keeping our fingers crossed! 

  1. Better Basics Laborbedarf GmbH(Mario Schneider)
  2. Intu Diagnostics GmbH(Dr. Dirk Kuhlmeier )
  3. Pacifico Biolabs GmbH(Washington Logroño)
  4. Dr. Purus Enorm Smart Technik GmbH(Dr. Bo Liu)
  5. goodBot GmbH(Dr. Julius Wiener)
  6. hema.to GmbH(Dr. Karsten Miermanns)
  7. IRUBIS GmbH(Anja Müller)
  8. Opto Biolabs GmbH(Dr. Kathrin Brenker)
  9. Safia Technologies GmbH(Dr. Timm Schwaar)
  10. CamSens GmbH(Enrika Barreto

In addition, the challenges of the financing environment were again discussed from various perspectives. The desire for a European capital market that would combine the strengths of Frankfurt, Euronext and NASDAQ Europe was articulated fairly unanimously. From our point of view as a specialist insurance broker, this is also desirable, although the standardization of the liability framework would certainly become even more challenging, so that different solutions for each stock exchange would no longer be necessary, as is currently the case.  

In conclusion, we are delighted to have been part of these events and will be back at the next one in Leipzig. Thanks also to the team of Plattform Life Sciences and Going Public Media AG for the great organization and the successful framework of the event! We had a lot of fun. 

Also read our other blog posts

Management

OLG Cologne: Insurer clarifies burden of proof for direct claim in D&O insurance

Cologne Higher Regional Court finally provides clarification in the area of D&O direct litigation with a recent ruling A new and exciting ruling from the world of D&O insurance. The proceedings dealt with the question of who bears the burden of proof if a company does not first take action against the managing director in an internal liability case, but instead takes direct action against the D&O insurer(s) (so-called direct action). This is possible if the defendant has assigned his/her indemnification claims against the D&O insurer to the company. But what happens in this case with the privileged

Read more "
Management

How managers protect themselves from personal liability in the event of cyber incidents - #29Minutes by Control Risk & Risk Partners

How directors and officers protect themselves from personal liability in the event of cyber incidents - #29Minutes by Control Risk & Risk Partners Looking at our claims experience in the area of directors' and officers' liability in recent years, internal claims alleging inadequate cyber risk management and emergency management in the event of a cyber attack are unfortunately on the rise. In addition to special risk transfer solutions (cyber and CDI insurance), there are also very practical tips on how to react correctly if the worst comes to the worst. Following an exchange at a risk management conference in Q1 of this year

Read more "
Life Sciences

Finance Day 2023

Growth capital for biotechnology: Yesterday, today, tomorrow! A few days ago, Jutta Zaglauer and Florian Eckstein from our team attended the Finance Day 2023 on the occasion of the 25th anniversary of biotechnology at the IZB - Innovation and Startup Center for Biotechnology. The event offered an exciting exchange and insights into current financing and capital market issues of biotechnology companies. As an experienced specialist insurance broker for the areas of life sciences, venture capital and IPOs, all three cornerstones of our "magic expertise triangle" were part of the exciting agenda. It was also interesting to discuss the importance of customized

Read more "
Your question has not been answered?
We will be happy to advise you in a free initial consultation.

Receive the Life Sciences Insurance Protection Guide free of charge!

Everything you need to know to optimally protect you and your life sciences / biotech company.